Americas

Argentina

Spanish

Brazil

Portuguese

Canada

Chile

Spanish

Colombia

Spanish

Mexico

Spanish

Peru

Spanish

United States

English

Asia Pacific

Europe

Austria

German

Belgium

Czech Republic

Czech

Denmark

Danish

Finland

Finnish

France

French

Germany

German

Greece

Greek

Hungary

Hungarian

Ireland

English

Italy

Italian

Luxembourg

English

Netherlands

Norway

Norwegian

Poland

Polish

Portugal

Portuguese

Romania

Romanian

Spain

Spanish

Sweden

Swedish

Switzerland

United Kingdom

English

Middle East

Israel

Hebrew

Saudi Arabia

Turkey

Turkish

United Arab Emirates

Other

Other Markets

Distributor Markets
Our Medicines

R&D expert voices

Learn more about the backgrounds, scientific pursuits and personal interests of members of our R&D team. These individuals are committed to pursuing Bristol Myers Squibb’s goal of discovering, developing and delivering transformational medicines to patients.

Ralston Barnes, PhD

Scientific Director of Transgenic Discovery, Discovery Biotherapeutics Bristol Myers Squibb

Neil Bence, PhD

Vice President, Head of Oncology Discovery

Edgar Charles, MD

Vice President, Global Program Lead, Immunology, Drug Development

Roland Chen, MD

Senior Vice President, Drug Development, Cardiovascular & Immunology Medicines

Justine Dell’Aringa

Senior Director, Translational Research, Cancer Immunology and Cell Therapy Thematic Research Center

Michael (Mike) Ellis, PhD

Senior Vice President, Head, Small Molecule Drug Discovery

Alison Fitch

Director, Scientific Operations and Strategy Immuno-Oncology and Cell Therapy Thematic Research Center

Claudia Generaux, PhD, MBA

Associate Director of Strategy and Business Development for Cardiovascular and Neuroscience

Richard Hargreaves, PhD

Senior Vice President, Neuroscience Thematic Research Center

Evan Janovitz, DVM, PhD, DAVCP

Director, Pathology, Discovery Toxicology

Ashley Koegel, MD

Executive Director, Early Clinical Development
Brisbane, CA

Emma Lees, PhD

Head, Mechanisms of Cancer Resistance Thematic Research Center

Michael May, PhD

Countrywide Medical Director, Germany, Global Medical

Leanne Peiser, PhD

Executive Director, Immuno-Oncology and Cellular Therapy Translational Development

Michael Pourdehnad

Vice President, Head of Early Clinical Development for Hematology, Oncology and Cell Therapy

Jinyi Zhu, PhD

Senior Principal Scientist, Protein Homeostasis Structural Biology

AltStyle によって変換されたページ (->オリジナル) /